(Q51960058)

19 April 2018

title

Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. (English)

1 reference

19 April 2018

7

Thomas P Monath

1 reference

19 April 2018

2

Frances K Newman

1 reference

19 April 2018

Sharon E Frey

1

object named as

Sharon E Frey

1 reference

19 April 2018

author name string

Jeffrey S Kennedy

3

1 reference

19 April 2018

Francis Ennis

4

1 reference

19 April 2018

Getahun Abate

5

1 reference

19 April 2018

Daniel F Hoft

6

1 reference

19 April 2018

language of work or name

English

0 references

publication date

9 December 2008

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

27

1 reference

19 April 2018

issue

10

1 reference

19 April 2018

page(s)

1637-1644

1 reference

19 April 2018

Response to smallpox vaccine in persons immunized in the distant past

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Duration of antiviral immunity after smallpox vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Clonal vaccinia virus grown in cell culture as a new smallpox vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Stability of Undiluted and Diluted Vaccinia‐Virus Vaccine, Dryvax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Epidemiologic investigation of a smallpox outbreak in a town reported to be "100 per cent vaccinated".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.079

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.11.079

1 reference

19 April 2018

1 reference

19 April 2018